- Home
- KRUS vs SBFM Comparison
KRUS vs SBFM Comparison
Compare KRUS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- SBFM
- Stock Information
- Founded
- KRUS 2008
- SBFM 2006
- Country
- KRUS United States
- SBFM United States
- Employees
- KRUS N/A
- SBFM N/A
- Industry
- KRUS Restaurants
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- KRUS Consumer Discretionary
- SBFM Health Care
- Exchange
- KRUS Nasdaq
- SBFM Nasdaq
- Market Cap
- KRUS 990.5M
- SBFM 6.6M
- IPO Year
- KRUS 2019
- SBFM N/A
- Fundamental
- Price
- KRUS $74.00
- SBFM $1.54
- Analyst Decision
- KRUS Buy
- SBFM Strong Buy
- Analyst Count
- KRUS 9
- SBFM 1
- Target Price
- KRUS $94.56
- SBFM $15.00
- AVG Volume (30 Days)
- KRUS 343.3K
- SBFM 188.9K
- Earning Date
- KRUS 07-08-2025
- SBFM 08-15-2025
- Dividend Yield
- KRUS N/A
- SBFM N/A
- EPS Growth
- KRUS N/A
- SBFM N/A
- EPS
- KRUS N/A
- SBFM N/A
- Revenue
- KRUS $269,327,000.00
- SBFM $36,234,578.00
- Revenue This Year
- KRUS $19.52
- SBFM $192.48
- Revenue Next Year
- KRUS $18.63
- SBFM N/A
- P/E Ratio
- KRUS N/A
- SBFM N/A
- Revenue Growth
- KRUS 18.76
- SBFM 35.51
- 52 Week Low
- KRUS $40.03
- SBFM $1.17
- 52 Week High
- KRUS $110.66
- SBFM $7.18
- Technical
- Relative Strength Index (RSI)
- KRUS 42.10
- SBFM 51.91
- Support Level
- KRUS $72.48
- SBFM $1.43
- Resistance Level
- KRUS $93.00
- SBFM $1.61
- Average True Range (ATR)
- KRUS 4.88
- SBFM 0.11
- MACD
- KRUS -1.78
- SBFM 0.01
- Stochastic Oscillator
- KRUS 7.41
- SBFM 41.67
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.